Atypical posterior reversible encephalopathy syndrome associated with Lenvatinib therapy in a patient with metastatic thyroid cancer—A case report

Atypical posterior reversible encephalopathy syndrome associated with Lenvatinib therapy in a patient with metastatic thyroid cancer—A case report

Abstract Posterior reversible encephalopathy syndrome (PRES) is a disorder of reversible subcortical vasogenic brain oedema in patients with acute neurological symptoms. Drug‐induced PRES has been described with the usage of drugs that target receptors regulating vascular permeability or altering im...

Full description

Bibliographic Details
Main Authors: Mahajan Abhishek, Ashtekar Renuka, Agarwal Ujjwal, Choudhari Amit, Patil Vijay, Noronha Vanita, Menon Nandini, Prabash Kumar
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Cancer Reports
Subjects:
drug‐induced posterior reversible encephalopathy syndromeradioimaging
head and neck cancer
immunotherapy
Lenvatinib
Online Access:https://doi.org/10.1002/cnr2.1605

Internet

https://doi.org/10.1002/cnr2.1605

Similar Items